Consistently, TRIM24-induced chemoresistance to 5-FU can be reversed by the AKT inhibitor LY294002, suggesting a regulatory relationship between TRIM24 and AKT signaling, resulting in chemotherapy in gastric cancer cells [80]. The gene discussed is TRIM24; the disease is gastric cancer.